KPV Dosage Chart
KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH, studied for anti-inflammatory activity through downregulation of NF-kB and pro-inflammatory cytokine signaling. It is orally active via PepT1 transport, which is why it appears both as an injectable vial and as oral capsules (Dalmasso et al., Gastroenterology 2008).
Half-life
Short (rapidly cleared systemically; acts intracellularly)
Format
Injectable
Purity
≥99%
Protocols
4 variants
Research Protocols
Dosage Protocols
Each row reflects a common research protocol variant. These are reference ranges derived from published literature and community research — not medical guidance.
Protocol 1
Standard Research Protocol (subcutaneous)
Dose
250-500mcg once daily
Duration
4-8 weeks
Most commonly cited research range for systemic anti-inflammatory exploration. Administered subcutaneously; rotate sites. Reassess after 4 weeks before extending.
Protocol 2
Oral / Gut-Focused Protocol
Dose
250mcg 1-2 times daily (oral capsule)
Duration
4-8 weeks
KPV's PepT1-mediated uptake makes the oral route viable for gut-localized research. Matches the common 250mcg capsule format. Taken with or without food.
Protocol 3
Elevated Research Protocol
Dose
500mcg-1mg daily
Duration
3-6 weeks
Upper end of the reported research range. Limit duration and revert to the standard protocol thereafter.
Protocol 4
Maintenance Protocol
Dose
250mcg every other day
Duration
Ongoing (cycled)
Reduced-frequency dosing used to preserve effect while lowering cumulative exposure after an initial phase.
Mixing Math
Reconstitution
Reference values for preparing a research vial. Adjust the syringe reading if you change the water volume.
Vial size
10mg vial
BAC water
2ml bacteriostatic water
Concentration
5mg/ml (5000mcg/ml)
Dose / ml
250mcg = 0.05ml · 500mcg = 0.1ml
Syringe units
5 IU (250mcg) · 10 IU (500mcg) on a U-100 syringe
Frequently Paired
Common Stacks
Storage
Handling Notes
Lyophilized: 2-8°C preferred, -20°C for extended storage. Reconstituted: refrigerate at 2-8°C and use within about 28 days. Protect from light. Oral capsules store at room temperature, sealed and dry.
Research Considerations
Cautions
- KPV is a research compound not approved for human use. Source only COA-verified material.
- Anti-inflammatory activity is derived largely from cell and animal models; human clinical data is limited.
- Gut-focused protocols are exploratory; there is no established therapeutic dose.
Ready to start your research
Get KPV from Ascension Peptides
COA-verified, US-based, discreet shipping. Use code ENHANCED for 50% off your entire order.
Buy KPV nowResearch use only. Not medical advice. Browse all dosage charts